نتائج البحث - "Zbyszewski, Patrick S."

1

Academic Journal

Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive care

المؤلفون: Nazha, Aziz, Sekeres, Mikkael A., Komrokji, Rami, Steensma, David P., Kantarjian, Hagop, Roboz, Gail, Fenaux, Pierre, Prebet, Thomas, Azarnia, Nozar, Zbyszewski, Patrick S., Fruchtman, Steven M., Santini, Valeria, Silverman, Lewis R., Platzbecker, Uwe, Garcia-Manero, Guillermo

المصدر: Blood Cancer Journal ; volume 7, issue 12 ; ISSN 2044-5385

الاتاحة: http://dx.doi.org/10.1038/s41408-017-0018-7
https://www.nature.com/articles/s41408-017-0018-7.pdf
https://www.nature.com/articles/s41408-017-0018-7

View record in BASE

2

Academic Journal

Analysis of professional competencies for the clinical research data management profession: implications for training and professional certification

المؤلفون: Zozus, Meredith N, Lazarov, Angel, Smith, Leigh R, Breen, Tim E, Krikorian, Susan L, Zbyszewski, Patrick S, Knoll, Shelly K, Jendrasek, Debra A, Perrin, Derek C, Zambas, Demetris N, Williams, Tremaine B, Pieper, Carl F

المساهمون: National Library of Medicine, National Institutes of Health

المصدر: Journal of the American Medical Informatics Association ; volume 24, issue 4, page 737-745 ; ISSN 1067-5027 1527-974X

مصطلحات موضوعية: Health Informatics

الاتاحة: http://dx.doi.org/10.1093/jamia/ocw179
http://academic.oup.com/jamia/article-pdf/24/4/737/34148934/ocw179.pdf

View record in BASE

3

Patent

AUTOMATED METHOD OF DISPLAYING AND UPDATING THE STATUS OF CLINICAL RESEARCH SITES IN A CLINICAL TRIAL TO IDENTIFY READINESS OF SITES TO ACCEPT PATIENTS

View record in USPTO Patent Applications

4

Academic Journal

Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 study

المؤلفون: Navada, Shyamala C., Garcia-Manero, Guillermo, OdchimarReissig, Rosalie, Pemmaraju, Naveen, Alvarado, Yesid, Ohanian, Maro N., John, Rosmy B., Demakos, Erin P., Zbyszewski, Patrick S., Maniar, Manoj, Woodman, Richard C., Fruchtman, Steven M., Silverman, Lewis R.

المساهمون: Onconova Therapeutics, Inc

المصدر: Leukemia Research ; volume 94, page 106369 ; ISSN 0145-2126

الاتاحة: http://dx.doi.org/10.1016/j.leukres.2020.106369
https://api.elsevier.com/content/article/PII:S0145212620300746?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0145212620300746?httpAccept=text/plain

View record in BASE

5

Academic Journal

A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia

المؤلفون: Navada, Shyamala C., Fruchtman, Steven M., Odchimar-Reissig, Rosalie, Demakos, Erin P., Petrone, Michael E., Zbyszewski, Patrick S., Holland, James F., Silverman, Lewis R.

المصدر: Leukemia Research ; volume 64, page 10-16 ; ISSN 0145-2126

الاتاحة: http://dx.doi.org/10.1016/j.leukres.2017.11.006
https://api.elsevier.com/content/article/PII:S0145212617305842?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0145212617305842?httpAccept=text/plain

View record in BASE

6

Periodical

Mutational Landscape of MDS Patients with HMA Failure Revealed By the Correlative Analysis from Inspire Trial

المؤلفون: Takahashi, Koichi, Jonasova, Anna, Luger, Selina M., Al-Kali, Aref, Valcarcel, David, Warlick, Erica D., Diez-Campelo, Maria, Keng, Michael K, Wang, Feng, Furudate, Ken, Zbyszewski, Patrick S., Parris, Matthew, Fruchtman, Steven M., Garcia-Manero, Guillermo

المصدر: Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p1517-1517, 1p

Full Text Finder

7

Periodical

Phase 3, Multi-Center, International, Randomized, Double-Blind, Placebo Controlled Study of Oral Rigosertib + Injectable Azacitidine (AZA) Versus Injectable Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS)

المؤلفون: Garcia-Manero, Guillermo, Navada, Shyamala C., Fenaux, Pierre, Zbyszewski, Patrick S., Adesanya, Afoluso Ronnee, Azarnia, Nozar, Fruchtman, Steven M., Silverman, Lewis R.

المصدر: Blood; November 2019, Vol. 134 Issue: Supplement 1 p4268-4268, 1p

Full Text Finder

8

Periodical

Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

المؤلفون: Navada, Shyamala C., Garcia-Manero, Guillermo, Atallah, Ehab L., Rajeh, M. Nabeel, Shammo, Jamile M., Griffiths, Elizabeth A., Khaled, Samer K., Dakhil, Shaker R., Young, David E., Odchimar-Reissig, Rosalie, Adesanya, Afoluso Ronnee, Zbyszewski, Patrick S., Woodman, Richard C., Fenaux, Pierre, Silverman, Lewis R.

المصدر: Blood; November 2019, Vol. 134 Issue: Supplement 1 p566-566, 1p

Full Text Finder

9

Periodical

Genomic Profiling in Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS) Following HMA Failure: Baseline Results from the Inspire Study (04-30)

المؤلفون: Garcia-Manero, Guillermo, Jonasova, Anna, Luger, Selina M., Al-Kali, Aref, Valcárcel, David, Warlick, Erica D., Jedrzejczak, Wieslaw W., Díez-Campelo, María, Zbyszewski, Patrick S., Cavanaugh, Christopher, Woodman, Richard C., Fruchtman, Steven M., Takahashi, Koichi

المصدر: Blood; November 2019, Vol. 134 Issue: Supplement 1 p3015-3015, 1p

Full Text Finder

10

Periodical

Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety Results in HMA Treatment Naïve & Relapsed (Rel)/Refractory (Ref) Patients

المؤلفون: Navada, Shyamala C., Garcia-Manero, Guillermo, Atallah, Ehab L., Rajeh, M. Nabeel, Shammo, Jamile M., Griffiths, Elizabeth A., Khaled, Samer K., Dakhil, Shaker R., Young, David E., Odchimar-Reissig, Rosalie, Pemmaraju, Naveen, Alvarado, Yesid, Ohanian, Maro N., John, Rosmy B., Zbyszewski, Patrick S., Maniar, Manoj, Petrone, Michael E., Fruchtman, Steven M., Silverman, Lewis R.

المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p230-230, 1p

Full Text Finder

11

Periodical

Amelioration of Rigosertib Treatment Related Genitourinary (GU) Adverse Events (AEs) in Patients with Myelodysplastic Syndromes: Implementation of Novel Dosing Regimen Derived through Pharmacokinetic Modeling in Phase 2 Study of Oral Rigosertib in Combination with Azacitidine

المؤلفون: Taft, David, Vora, Tarang, Ren, Chen, Zbyszewski, Patrick S., Morgan, Joseph, Petrone, Michael E., Fruchtman, Steven M., Maniar, Manoj

المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p4379-4379, 1p

Full Text Finder

12

Periodical

Evaluation of Underlying Cause of Genitourinary (GU) Adverse Events (AEs) in Patients with Myelodysplastic Syndromes upon Oral Administration of Rigosertib: Safety and Pharmacokinetic Analysis of Rigosertib across Three Clinical Trials

المؤلفون: Maniar, Manoj, Ren, Chen, Zbyszewski, Patrick S., Petrone, Michael E., Fruchtman, Steven M., Taft, David

المصدر: Blood; November 2018, Vol. 132 Issue: 1, Number 1 Supplement 1 p3106-3106, 1p

Full Text Finder

13

Periodical

Rigosertib Oral in Transfusion Dependent Lower Risk Myelodysplastic Syndromes (LR-MDS): Optimization of Dose and Rate of Transfusion Independence (TI) or Transfusion Reduction (TR) in a Single-Arm Phase 2 Study

المؤلفون: Raza, Azra, Al-Kali, Aref, Tibes, Raoul, Spitzer, Gary, Gaddh, Manila, Tycko, Benjamin, Lee, Sangmin, Galili, Naomi, Ali, Abdullah Mahmood, Mears, John G., Mukherjee, Siddhartha, Shelton, Ryan, Fruchtman, Steven M., Petrone, Michael E., Zbyszewski, Patrick S., Heaney, Mark Lawrence

المصدر: Blood; December 2017, Vol. 130 Issue: 1, Number 1 Supplement 1 p1689-1689, 1p

Full Text Finder

تنقيح النتائج